Bone health management varies across hospitals for older women with early breast cancer who have inconsistent bone density ...

Cassandra and Katelyn Harding suffered the loss of their mother before both being diagnosed with rare osteosarcoma ...

Gedatolisib combined with Faslodex and Ibrance improved progression-free survival in patients with advanced breast cancer ...

A study published in The Annals of Family Medicine examined if gaining housing increased rates of colorectal and breast ...

A phase 3 trial of Celcuity’s breast cancer combination has hit its primary endpoints, blasting past the biotech’s bar for ...

Celcuity shares soar 186% after Phase 3 breast cancer trial shows triple therapy delays disease by over 7 months.

In keeping with its mission to deliver excellent, compassionate, and accessible healthcare for every Filipino, Medical Center ...

At a stroke, the data gives Celcuity a potential advantage over already-marketed oral PI3K inhibitors like Novartis' Piqray/Vijoice (alpelisib) and Roche's Itovebi (inavolisib), which are currently ...

The drug, gedatolisib, in combination with Pfizer's Ibrance and AstraZeneca's endocrine therapy Faslodex, reduced the risk of ...

Celcuity shares jump as gedatolisib shows strong efficacy in HR+/HER2- breast cancer Phase 3 trial, with FDA filing expected ...

A Northeastern University researcher has identified a way to target two of the deadliest cancer types, melanoma and triple ...

There’s overwhelming community support for a beloved Montgomery County restaurant owner fighting Stage 4 breast cancer. WTOP’s Kate Ryan has the story of Ada Villatoro.